Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis - Mestre-Gómez, B.; Lorente-Ramos, R. M.; Rogado, J.; Franco-Moreno, A.; Obispo, B.; Salazar-Chiriboga, D.; Saez-Vaquero, T.; Torres-Macho, J.; Abad-Motos, A.; Cortina-Camarero, C.; Such-Diaz, A.; Ruiz-Velasco, E.; et al. (Journal of thrombosis and thrombolysis, 2021)
Keywords: Angiography; Anticoagulants - therapeutic use; Cardiology; Causality; Chemoprevention - methods; Chemoprevention - statistics & numerical data; Computed tomography; Computed Tomography Angiography - methods; Coronaviruses; COVID-19; COVID-19 - complications; COVID-19 - diagnosis; COVID-19 - drug therapy; COVID-19 - physiopathology; Diagnosis; Dyslipidemia; Electronic Health Records - statistics & numerical data; Electronic medical records; Embolism; Female; Fibrin Fibrinogen Degradation Products - analysis; Hematology; Heparin; Hospitalization - statistics & numerical data; Humans; Incidence; Lung - blood supply; Lung - diagnostic imaging; Male; Medicine; Medicine & Public Health; Middle Aged; Molecular weight; Multivariate analysis; Pandemics; Patients; Pulmonary Embolism - blood; Pulmonary Embolism - diagnostic imaging; Pulmonary Embolism - epidemiology; Pulmonary Embolism - etiology; Pulmonary embolisms; SARS-CoV-2 - isolation & purification; Severe acute respiratory syndrome coronavirus 2; Spain - epidemiology; Thrombophilia - diagnosis; Thrombophilia - etiology; Spain; COVID-19; Pulmonary embolism; Hypercoagulable state; Computed tomography pulmonary angiography; Antithrombotic therapy